The Spectrum of Diagnosis and Management of Headaches in Pediatric Emergency Department (P04.172)

Autor:	Soe Mar, Sushant P. Kale, Arthur L. Prensky, Jason Lenox, Shubhangi Peche, Sara Isbell
Rok vydání:	2012
Předmět:	Pediatrics medicine.medical_specialty business.industry Analgesic Pre-Medication Emergency department Triptans medicine.disease Migraine Health care medicine Neurology (clinical) Medical diagnosis Headaches medicine.symptom business medicine.drug
Zdroj:	Neurology. 78:P04.172-P04.172
ISSN:	1526-632X 0028-3878
Popis:	Objective: To analyze the diagnoses and management of children presenting with Headaches as a chief complaint. Background Headaches in Children and adolescents are common presenting complaints in emergency department. The prevalence of headache ranges from 37-51% during the elementary school years and gradually rises to 57-82% by the high school years. Headaches have a significant impact on the lives of children and adolescents, resulting in school absence, decreased extracurricular activities, and poor academic achievement.There is wide variation among acute treatments and their effectiveness. Design/Methods: Retrospective chart review of patients presenting with headache to St. Louis Children9s Hospital ER between 2007 to 2010. 1499 charts with presenting diagnosis of Headache according to ICD 9 code were reviewed.Headaches were classified in to Primary, Secondary and non classifiable.Migraine patients were further analyzed to review Pre medication pain score (PRPS), Post medication pain score (POPS), and type of medication used ( Oral, IV or combination). Kruskal-wallis test, Rank Analysis of Covariance tests were used for statistical analysis. Results: Oral medications had statistically significant lower mean pre-pain score (p=0.01). Triptans and combination of triptans and Ibuprofen were given to patients with higher PRPS (p Conclusions: Majority of ER visits were due to migraine or other minor illnesses that required outpatient analgesic treatment. Cost of healthcare and use of ER resources could be significantly reduced if they could be treated in Non ER setting. Prospective, controlled trials are needed. Disclosure: Dr. Peche has nothing to disclose. Dr. Lenox has nothing to disclose. Dr. Isbell has nothing to disclose. Dr. Kale has nothing to disclose. Dr. Mar has nothing to disclose. Dr. Prensky has nothing to disclose.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::ff0aef1d10d9cc884719cf469f720eb9 https://doi.org/10.1212/wnl.78.1_meetingabstracts.p04.172 Zobrazit plný text záznamu